1.Impact of Climate Warming on Schistosomiasis Transmission and Application of Relative Research Techniques
Chinese Journal of Parasitology and Parasitic Diseases 1987;0(03):-
Oncomelania hupensis is the intermediate host of Schistosoma japonicum, and its distribution is consistent with that of schistosomiasis.Temperature is an essential environmental factor for the survival of snails.Therefore, it is important to study the impact of climate warming on snail-breeding and schistosomiasis transmission.This paper reviews the importance of climate warming to snail breeding and the spreading of the disease, and the application of relative research techniques.
2.Research on motives and influence factors of scientific research of nursing staff
Jinlian CHENG ; Yinping CHU ; Shifan HAN ; Hongrui SHI ; Xiujuan DONG
Chinese Journal of Medical Science Research Management 2012;(6):366-371
Objective To analyse the research motives and its influencing factors of nursing staff.Methods 1000 authors who wrote for “Nursing Research” were chosen with a random code sampling method and were surveyed with a questionnaire,which inquired about their research motivation and self-rated research ability scale.Results Nursing research motives include to summarise clinical experience66.2% (524/793),to get promotion 55.4% (420/793),to contribute to nursing profession 37.2% (295/793),to report research achievements 35.6% (282/793),and to meet the requirements of the institution17.5% (139/793).Research motives were statistically different in terms of age,work expirence,educational background,professional title,attitude,research training,research ability,and work institution (P =0.013,0.037,0.048,0.002,0.024,0.008,0.005,0.009,0.004,P<0.05).Conclusions To stimulate the enthusiasm for research in nursing staff,administrators need to pay great attention to higher education for nurses,enhance their research training,provide research platform,and to improve the incentive system.
3.Analysis of citations of literatures of nursing staff from quotations of five nursing periodicals from year 2010 to 2012
Jinlian CHENG ; Yinping CHU ; Shifan HAN ; Xiujuan YE
Chinese Journal of Medical Science Research Management 2016;29(2):139-143
Objective To investigate the habits that literatures using by nursing staffs during 2010 to 2012 in China.Methods The publication from Chinese Journal of Nursing, Nursing Research, Chinese Journal of Practical Nursing, Journal of Nurses Training and Journal of Nursing Science from year of 2010 to 2012 were statistically analyzed using literature metrology method.The statistics results were compared with data from 2007 to 2009.Results In past 3 years, the quantity,quantity of papers with citations, average number of citations, citations of theses with citations published in-mentioned above five periodicals increased year by year.In 2010 to 2012, the average number of citations and citations rate of papers also improved compared with 2007 to 2009.The type citation is mainly from Journals,and the language was mainly in Chinese.Conclusions In the past 3 years, the nursing staff's literature utilization was improved.However, in the situation of using references with foreign language, nursing staff was poor comparing with medical personnel.On the scientific research ability of nursing personnel training should be strengthened,and the application of new technology and new theory in domestic and international should be strengthened as well..
4.Analysis of inflnencing factors for research papers publication by 750 nursing staff
Jinlian CHENG ; Yinping CHU ; Shifan HAN ; Hongrui SHI ; Xiujuan DONG
Chinese Journal of Hospital Administration 2012;28(7):528-532
Objective To learn the publications and influencing factors of scientific papers from nursing staff in China.Methods 750 authors were chosen in a stratified random sampling for survey,and the questionnaires included a survey form on nursing research papers publications and one research ability self-rating scalce Results The nursing staff surveyed published 1-70 papers per person,averaging 8.83papers per person; on average 0.45 papers were published per person per year.Main factors for research outputs range from high to low as follows:age,academic titles,research ability,education background and research training,with the Beta values of 0.255,0.234,0.142,0.093,and 0.087 respectively.Conclusion Nursing administrators need to develop respective objectives for nursing staff of different age,academic titles,education background and research ability,and set up an effective incentive mechanism to ignite the enthusiasm of scientific research.
5.Efficacy of 3LL/GM-CSF tumor vaccine combined with pacilitaxel chemotherapy in treatment of mice bearing transplanted Lewis lung carcinoma
Xiujuan ZHENG ; Lei ZHANG ; Yi LIN ; Yi ZHANG ; Hongming HU ; Yiwei CHU
Chinese Journal of Cancer Biotherapy 2006;0(06):-
Objective: To evaluate the efficacy of 3LL/GM-CSF tumor vaccine combined with pacilitaxel chemotherapy in treatment of mice bearing transplanted Lewis lung carcinoma. Methods: The tumor vaccine 3LL/GM-CSF was prepared by infecting Lewis lung carcinoma cell line 3LL with adenovirus encoding GM-GSF. Mice model of Lewis lung carcinoma was established by subcutaneous injection of 2?104 3LL cells into C57BL/6(H-2b)mice. The sensitivity of Lewis lung carcinoma cell line-3LL to the treatment of pacilitaxel was detected in vivo and in vitro. The mice tumor model was first treated with pacilitaxel chemotherapy and then with 3LL/GM-CSF, or first with 3LL/GM-CSF and then with pacilitaxel. Tumor growth and the long-term survival of mice were observed after treatment. The immune memory and cytotoxicity against target cells were studied in the mice. Results: Pacilitaxel at 100 nmol/L killed 32.10% 3LL cells after 24 hour in vitro; but pacilitaxel at 5-25 mg/kg only had a poor effect on growth of 3LL cells in vivo. The tumors rebated in 70% of mice treated with pacilitaxel chemotherapy and 3LL/GM-CSF vaccination successively, and the survival of these mice was obviously longer than that of pure pacilitaxel chemotherapy group (70.0 days vs 27.5 days). The killing rate of 3LL/GM-CSF after pacilitaxel chemotherapy was 41.35% on day 3. Meanwhile, the survival mice could resist the re-attack of 3LL cells (2?104). We also noticed that first treatment with 3LL/GM-CSF and then pacilitaxel chemotherapy had no effect on tumors. Conclusion: Application of tumor vaccine shortly after pacilitaxel chemotherapy can induce specific immune responses and prolong the survival of experimental mice, which provide a basis for future clinical practice.
6.Study on p21 gene knock out in G401 cell line by using CRISPR/Cas9 system
Xiujuan ZHAO ; Wanbiao CHEN ; Peitao ZHANG ; Na ZHANG ; Xiaowen CHU ; Xiangyang BAI ; Bing YANG ; Xudong WU ; Xi WANG
Tianjin Medical Journal 2016;44(10):1190-1194
Objective To knock out p21 gene in human malignant rhab doid tumor(MRT)cell line G401 by using CRISPR/Cas9 genome engineering technology. Methods The expression of p21 was detected by reverse transcription quantitative PCR (RT-qPCR) and Western blot assay in several MRT cell lines. The guide RNA was designed by targeting the third exon of p21 gene,which encoded its home domains, and then subcloned into lentiCRISPR v2 vector and validated sequencing. The validated plasmids were further used to package and produce the lentivirus in 293T cells, and the G401 cells were infected, then puromycin was used to screen positive cells, and the clusters of G401 monoclonal cells, were obtained by selecting monoclonal cells and culturing under the microscope. The RNA and protein of new clonal cell line were extracted, and RT-qPCR and Western blot assay were applied to confirm whether p21 was successfully knocked out. Results The p21 was highly expressed in MRT tumor cells. The CRISPR/Cas9 lentivirus plasmids, targeted p21 gene were successfully constructed. Compared with negative control group,the expression of p21 was not detected in G401 monoclonal cells, which were successfully screened. Conclusion In view of the difficult transfection of cells such as G401, p21 knockout stable cell line has been successfully constructed by using CRISPR/Cas9 system, which lays the foundation for further study of the mechanism of p21 in MRT tumors .
7.Antimlcrobial resistance analysis among nosocomial gram-negative bacilli from 10 teaching hospitals in China in 2006
Hui WANG ; Miajun CHEN ; Yuxing NI ; Qinglian KONG ; Yaning MEI ; Yunsong YU ; Kang LIAO ; Ziyong SUN ; Zhidong HU ; Yunzhuo CHU ; Xinhong HUANG ; Xiujuan YU ; Wangsheng ZHAO ; Yingchun XU ; Xiuli XIE
Chinese Journal of Laboratory Medicine 2008;31(6):623-627
Objective To investigate antimicrobial resistance among nosocomial gram-negative bacilli in 2006.Methods About 987 consecutive and non-repetitive gram-negative bacilli were isolated from 10 teaching hospitals from Sep.to Dec.in 2006 in China.All of these isolates were sent to the central laboratory for reidentification and susceptibility testing.The minimal inhibitory concentration(MICs)of meropenem and other antibacterial agents were determined by agar dilution method.Results The activity of antibacterial agents against Enterobacteriaceae was as fol lows in descending order of susceptible rate: meropenem(susceptible rate 99.8%),imipenem(99.5%),piperacillin/tazobactam(91.3%),amikacin (89.3%),cefepime(83.8%),cefoperazone/sulbactam(79.7%),ceftazidime(74.7%),cefotaxime (57.7%),ceftriaxone(56.6%),ciprofloxacin(53.6%).The prevalence of extended-spectrum β-Iactamases(ESBL)was 59.0% in Escherichia coli,33.0%in Klebsiella pneumoniae and 8.0%in Proteus mirabilis.The most active agents against E.coli and K.pneumoniae were meropenem,imipenem(99.2%. 100%),piperacillin/tazobactam(90.8%-97.0%),and amikacin(83.8%-92.4%).Cefepime Was more active against K.pneumoniae than E.coli(85.4% vs.65.2%).Against E.cloacae,E.aerogenes and Citrobacter freundii,the most active agents were as follows in desecnding order:meropenem,imipenem (99.2%-100%),amikacin(85.2%-92.6%),cefepime(81.5%-85.9%),piperacillin/tazobactam (73.4%-87.2%),cefoperazone/sutbactam(65.6%-77.7%),and ciprofloxacin(53.1%-72.3%).The most active agents against Pseudomonas aeruginosa were amikacin(83.5%),followed by meropenem (79.1%),piperacillin/tazobactam(74.1%),and imipenem(70.9%).The most susceptible agents against Acinetobacter baumannii were imipenem(79.1%),meropenem(73.4%) and cefoperazone/ sulbaetam(54.7%).Mutiresistant A.baumannii increased up to 53.0%.The most active agents against Burkholderia cepacia were meropenem(73.3%),eeflazidime(73.3%),and piperacillin/tazobactam (62.2%).Conclusions Carbapenems remained very high activity against Enterobacteriaceae.Increasing resistance to 10 antimicrobials agents tested from A.baumanni and P.aeruginosa brought great concern.
8.Discriminant analysis of the risk of nosocomial mortality in patients with traumatic hemorrhagic shock
Xiujuan ZHAO ; Chu WANG ; Wei HUANG ; Panpan CHANG ; Fuzheng GUO ; Zhenzhou WANG ; Fengxue ZHU ; Tianbing WANG
Chinese Journal of General Surgery 2021;36(8):608-611
Objective:To investigate the use of discriminant analysis to predict the risk of nosocomial mortality in patients with traumatic hemorrhagic shock.Methods:The clinical data of 238 patients with traumatic hemorrhagic shock admitted to Peking University People's Hospital from Sep 2013 to Aug 2020 were retrospectively analyzed. Patients were divided into survival group (214 cases) and death group (24 cases). Stepwise discriminant analysis was used to establish a discriminant model.Results:The difference of history of stroke (9.8% vs. 25.0%), main site of bleeding (extremities)(58.9% vs. 29.2%), APACHEⅡ score (16.4±5.1 vs. 23.2±6.1), blood lactic acid [2.1(1.1-3.5) mmol/L vs. 4.9(2.0-13.4) mmol/L] and surgery (92.5% vs. 58.3%) between the two groups was all statistically significant (all P<0.05). Finally, There are five indicators that entered the discriminant model: history of stroke, main site of bleeding (extremities), blood lactic acid, APACHE Ⅱ score and surgery. The area under the ROC curve for predicting the risk of mortality in patients with traumatic hemorrhagic shock was 0.857, 95% CI 0.754-0.959. Conclusions:The established discriminant model has a high accuracy in predicting the risk of in-hospital mortality in patients with traumatic hemorrhagic shock.
9.Antimicrobial resistance analysis among nosocomial gram-negative bacilli from 10 teaching hospitals in China
Hui WANG ; Minjun CHEN ; Yuxing NI ; Dongmei CHEN ; Ziyong SUN ; Yan CHEN ; Wangsheng ZHAO ; Xiong ZOU ; Yunsong YU ; Zhidong HU ; Xinhong HUANG ; Yingchun XU ; Xiuli XIE ; Yunzhuo CHU ; Qian WANG ; Yaning MEI ; Bin TIAN ; Pei ZHANG ; Qinglian KONG ; Xiujuan YU ; Yuhong PAN
Chinese Journal of Laboratory Medicine 2003;0(12):-
80% activity rate against E.coli included piperacillin/tazobactam(93.4%)、ceftazidime(86%),and amikacin(83.3%);The susceptible rate to piperacillin/tazobactam in K.pneumoniae was 84.6%. The susceptible rate to ceftazidime decreased from 82.3% to 69.9%, which was lower than to cefepime (77.2%). Over 50% of Enterobacter cloacae were resistant to ceftazidime, cefotaxime and ceftriaxone. Susceptible rates to piperacillin/tazobactam in E. cloacae,E. aerogenes,Citrobacter freundii and Serratia marcescens (67.7%-96.4%) were higher than those to cefepime (68.8%-77.5%), cefoperazone/sulbactam (59.7%-87.5%). Susceptibility to amikacin among these 4 species (70%-83.7%) was higher than to ciprofloxacin (48.1%-79.5%). All of Morganella morganii and Proteus vulgaris isolates were susceptible to meropenem and imipenem; Over 90% of the isolates were susceptible to cefepime, cefoperazone/sulbactam and piperacillin/tazobactam.The most active agent against Pseudomonas aeruginosa was meropenem (84%), followed by amikacin, piperacillin/tazobactam, ceftazidime and imipenem (72.5%-76.6%). Mutiple-drug-resistant Acinetobacter baumannii increased from 33% in 2003 to 48% in 2004. Resistance to carbapenems increased to 18% in this species in 2004. The most active agents against Burkholderia cepacia were meropenme (64.9%), cefoperazon/sulbactam (63.2%), ceftazidime (59.6%), piperacillin/tazobactam (56.1%) and cefepime (52.6%).Conclusions Carbapenems remained very high activity against Enterobacteriaceae. Increasing resistance to 10 antimicrobials agents tested among A. baumanni brought great concern. Meropenem was 4-to 16-fold more active against common gram-negative bacilli than imipenem.
10. Association between electromyography and magnetic resonance neurography in patients with typical chronic inflammatory demyelinating polyradiculoneuropathy
Yuan FENG ; Xiaoyun SU ; Hong CHU ; Shuping LIU ; Xiujuan FU ; Xiangquan KONG ; Zuneng LU
Chinese Journal of Neurology 2019;52(11):912-918
Objective:
To explore the association among clinical features, electromyography (EMG) and magnetic resonance neurography (MRN) in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Methods:
A cross-sectional survey was conducted to enroll consecutively typical CIDP patients in Renmin Hospital of Wuhan University from May 2017 to May 2019. The Hughes Disability Scale (HDS) was used to evaluate the illness severity of the patients. The electrodiagnostic parameters including motor conduction velocity (MCV), compound muscle action potential (CMAP), F-wave latency, sensory nerve conduction velocity (SCV) and sensory nerve action potential (SNAP) of upper and lower limbs were analyzed. The patients whose response waveform can be elicited in all nerves were defined as group A, and those without response in one or more nerves as group B. MRN quantitative technique was used to calculate the cross-sectional area of nerves roots (nr-CSA) of brachial plexus and lumbosacral plexus. The linear regression method was used to analyze the correlation among clinical features, EMG and nr-CSA.
Results:
A total of 32 patients with typical CIDP met the criteria, 75% (24/32) of whom were males. There were 16 patients in the mild group (group A) and 16 in the severe one (group B). The abnormal rate of F-wave latency was the highest. Cerebrospinal fluid (CSF) protein, HDS score were correlated significantly with the nr-CSA of brachial plexus and lumbosacral plexus in the two groups (group A: CSF protein and brachial plexus nr-CSA: